Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | T. Yoshino, H. Iwata, K. Tamura, S. Takahashi, C. Redfern, S. Modi, T. Doi, H. Kawakami, H. Taniguchi, A. Takashima, K. Yamaguchi, J. Fisher, B. Li, K. Saito, Y. Fujisaki, M. Sugihara, J. Tsurutani | ||||||||||||
Title | Updated results of phase 1 study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer | ||||||||||||
|
|||||||||||||
URL | https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/Updated-results-of-phase-1-study-of-trastuzumab-deruxtecan-DS-8201a-in-HER2-expressing-advanced-colorectal-cancer | ||||||||||||
Abstract Text | Annals of Oncology (2018) 29 (suppl_8): viii150-viii204 10.1093/annonc/mdy281 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|